Solana (HSDT) vs InMode (INMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InMode (INMD) has outperformed Solana (HSDT) over the past year, losing 6.4% versus a loss of 86.8%. Over five years, INMD leads with a -83.1% price change compared with -100.0% for HSDT. InMode is the larger company by market cap ($810.2 million vs $154.9 million), about 5.2 times the size.
On valuation, Solana trades at a lower trailing P/E (0.0x vs 11.6x for InMode).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSDT | INMD |
|---|---|---|
| Share price | $2.38 | $14.08 |
| Market cap | $154.95M | $810.22M |
| 1-day change | -6.30% | +0.50% |
| YTD return | -17.65% | -4.15% |
| 1-year return | -86.80% | -6.45% |
| 5-year return | -100.00% | -83.11% |
| P/E ratio (TTM) | 0.04 | 11.64 |
| Forward P/E | — | 10.26 |
| EPS (TTM) | $53.74 | $1.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.97 | $16.74 |
| 52-week low | $1.19 | $12.72 |
| Distance from 52-week high | -86.76% | -15.89% |
| Analyst consensus | none | none |
| Avg. price target upside | +47.06% | +14.84% |
| Average volume | 349.89K | 521.98K |
| Shares outstanding | 65.10M | 57.54M |
| Employees | 21 | 660 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- InMode is about 5.2 times larger than Solana by market value ($810.22M vs $154.95M).
- INMD has outperformed HSDT by 80.4 percentage points over the past year.
- InMode trades at a higher earnings multiple (11.6x vs 0.0x trailing P/E).
About Solana
HSDT stock →Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 21 employees
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
HSDT vs INMD FAQ
Which is bigger, Solana or InMode?
InMode (INMD) is larger, with a market capitalization of $810.22M compared with $154.95M for Solana (HSDT).
Which stock has performed better over the past year, HSDT or INMD?
INMD returned -6.45% over the past 12 months, compared with -86.80% for HSDT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, HSDT or INMD?
HSDT has the lower trailing P/E at 0.0, versus 11.6 for INMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Solana and InMode in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.